Literature DB >> 24219064

Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2α and activating transcription factor 4 - A pathway active in glioblastomas and epilepsy.

Jan Lewerenz1, Paul Baxter, Rebecca Kassubek, Philipp Albrecht, Joeri Van Liefferinge, Mike-Andrew Westhoff, Marc-Eric Halatsch, Georg Karpel-Massler, Paul J Meakin, John D Hayes, Eleonora Aronica, Ilse Smolders, Albert C Ludolph, Axel Methner, Marcus Conrad, Ann Massie, Giles E Hardingham, Pamela Maher.   

Abstract

AIMS: Phosphoinositide 3-kinases (PI3Ks) relay growth factor signaling and mediate cytoprotection and cell growth. The cystine/glutamate antiporter system xc(-) imports cystine while exporting glutamate, thereby promoting glutathione synthesis while increasing extracellular cerebral glutamate. The aim of this study was to analyze the pathway through which growth factor and PI3K signaling induce the cystine/glutamate antiporter system xc(-) and to demonstrate its biological significance for neuroprotection, cell growth, and epilepsy.
RESULTS: PI3Ks induce system xc(-) through glycogen synthase kinase 3β (GSK-3β) inhibition, general control non-derepressible-2-mediated eukaryotic initiation factor 2α phosphorylation, and the subsequent translational up-regulation of activating transcription factor 4. This pathway is essential for PI3Ks to modulate oxidative stress resistance of nerve cells and insulin-induced growth in fibroblasts. Moreover, the pathway is active in human glioblastoma cells. In addition, it is induced in primary cortical neurons in response to robust neuronal activity and in hippocampi from patients with temporal lobe epilepsy. INNOVATION: Our findings further extend the concepts of how growth factors and PI3Ks induce neuroprotection and cell growth by adding a new branch to the signaling network downstream of GSK-3β, which, ultimately, leads to the induction of the cystine/glutamate antiporter system xc(-). Importantly, the induction of this pathway by neuronal activity and in epileptic hippocampi points to a potential role in epilepsy.
CONCLUSION: PI3K-regulated system xc(-) activity is not only involved in the stress resistance of neuronal cells and in cell growth by increasing the cysteine supply and glutathione synthesis, but also plays a role in the pathophysiology of tumor- and non-tumor-associated epilepsy by up-regulating extracellular cerebral glutamate.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24219064      PMCID: PMC4038988          DOI: 10.1089/ars.2013.5455

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  74 in total

Review 1.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.

Authors:  F Q Schafer; G R Buettner
Journal:  Free Radic Biol Med       Date:  2001-06-01       Impact factor: 7.376

Review 2.  Oncogenic mutations of PIK3CA in human cancers.

Authors:  Yardena Samuels; Todd Waldman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress.

Authors:  T H Murphy; M Miyamoto; A Sastre; R L Schnaar; J T Coyle
Journal:  Neuron       Date:  1989-06       Impact factor: 17.173

4.  Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas.

Authors:  N E Savaskan; S Seufert; J Hauke; C Tränkle; I Y Eyüpoglu; E Hahnen
Journal:  Oncogene       Date:  2010-08-30       Impact factor: 9.867

5.  Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals.

Authors:  Michael McMahon; Douglas J Lamont; Kenneth A Beattie; John D Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

6.  DHEA prevents Aβ25-35-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI3K-Akt-mTOR signaling.

Authors:  Liang Li; Bingzhong Xu; Ying Zhu; Lei Chen; Masahiro Sokabe; Ling Chen
Journal:  Neuropharmacology       Date:  2010-02-16       Impact factor: 5.250

7.  Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress.

Authors:  Jan Lewerenz; Julia Letz; Axel Methner
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

8.  Glutamate is associated with a higher risk of seizures in patients with gliomas.

Authors:  Tanya I Yuen; Andrew P Morokoff; Andrew Bjorksten; Giovanna D'Abaco; Lucy Paradiso; Sue Finch; Daniel Wong; Christopher A Reid; Kim L Powell; Kate J Drummond; Mark A Rosenthal; Andrew H Kaye; Terence J O'Brien
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

9.  A novel approach to enhancing cellular glutathione levels.

Authors:  Pamela Maher; Jan Lewerenz; Carles Lozano; Josep Lluís Torres
Journal:  J Neurochem       Date:  2008-08-12       Impact factor: 5.372

10.  Effect of insulin on the activity of amino acid transport systems in cultured human fibroblasts.

Authors:  N Longo; R Franchi-Gazzola; O Bussolati; V Dall'Asta; P P Foà; G G Guidotti; G C Gazzola
Journal:  Biochim Biophys Acta       Date:  1985-02-21
View more
  32 in total

Review 1.  Back to the future with phenotypic screening.

Authors:  Marguerite Prior; Chandramouli Chiruta; Antonio Currais; Josh Goldberg; Justin Ramsey; Richard Dargusch; Pamela A Maher; David Schubert
Journal:  ACS Chem Neurosci       Date:  2014-06-05       Impact factor: 4.418

2.  MAPK signaling triggers transcriptional induction of cFOS during amino acid limitation of HepG2 cells.

Authors:  Jixiu Shan; William Donelan; Jaclyn N Hayner; Fan Zhang; Elizabeth E Dudenhausen; Michael S Kilberg
Journal:  Biochim Biophys Acta       Date:  2014-12-16

3.  Cystathionine is a novel substrate of cystine/glutamate transporter: implications for immune function.

Authors:  Sho Kobayashi; Mami Sato; Takayuki Kasakoshi; Takumi Tsutsui; Masahiro Sugimoto; Mitsuhiko Osaki; Futoshi Okada; Kiharu Igarashi; Jun Hiratake; Takujiro Homma; Marcus Conrad; Junichi Fujii; Tomoyoshi Soga; Shiro Bannai; Hideyo Sato
Journal:  J Biol Chem       Date:  2015-02-20       Impact factor: 5.157

4.  GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling.

Authors:  Barbara D'Angelo; C Joakim Ek; Yanyan Sun; Changlian Zhu; Mats Sandberg; Carina Mallard
Journal:  Neuropharmacology       Date:  2015-09-15       Impact factor: 5.250

Review 5.  Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.

Authors:  Ann Massie; Séverine Boillée; Sandra Hewett; Lori Knackstedt; Jan Lewerenz
Journal:  J Neurochem       Date:  2015-09-29       Impact factor: 5.372

6.  Interleukin 1β Regulation of the System xc- Substrate-specific Subunit, xCT, in Primary Mouse Astrocytes Involves the RNA-binding Protein HuR.

Authors:  Jingxue Shi; Yan He; Sandra J Hewett; James A Hewett
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

Review 7.  Ferroptosis and Its Role in Diverse Brain Diseases.

Authors:  Abigail Weiland; Yamei Wang; Weihua Wu; Xi Lan; Xiaoning Han; Qian Li; Jian Wang
Journal:  Mol Neurobiol       Date:  2018-11-08       Impact factor: 5.590

Review 8.  Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis.

Authors:  Giles E Hardingham; Kim Q Do
Journal:  Nat Rev Neurosci       Date:  2016-01-14       Impact factor: 34.870

9.  Saturated fatty acids entrap PDX1 in stress granules and impede islet beta cell function.

Authors:  Mu Zhang; Chunjie Yang; Meng Zhu; Li Qian; Yan Luo; Huimin Cheng; Rong Geng; Xiaojun Xu; Cheng Qian; Yu Liu
Journal:  Diabetologia       Date:  2021-02-11       Impact factor: 10.122

Review 10.  Using the Oxytosis/Ferroptosis Pathway to Understand and Treat Age-Associated Neurodegenerative Diseases.

Authors:  Pamela Maher; Antonio Currais; David Schubert
Journal:  Cell Chem Biol       Date:  2020-11-10       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.